title: Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.
abstract: OBJECTIVE
  The prognostic values of serum thyroglobulin (Tg) and antithyroglobulin antibody (TgAb) levels, measured immediately before I-131remnant ablation in patients with differentiated thyroid cancer (DTC), have been advocated by some researchers; however, it had controversial outcomes. This study was carried out to examine this dilemma and to check the clinical significance of basal serum Tg and TgAb levels and postablation iodine 131whole body scan(WBS) findings in DTC patients.
  
  
  METHODS
  In this retrospective study, the records of 500 patients with differentiated thyroid cancer, who had undergone treatment between 2003 and 2010, were assessed. Of those, 149 patients with results of basal serum thyroglobulin concentration and whole body scan using radioactive iodine were included. Age, sex, tumour histology, basal thyroglobulin (Tg), anti-thyroglobulin (TgAb) and TSH concentration, radioactive iodine doses in each hospitalization, numbers of hospitalization, and results of whole body scans were recorded. The relationship among basal Tg, TgAb, TSH, and whole body scan with hospitalization number and total radioactive iodine doses were assessed.
  
  
  RESULTS
  A total of 149 patients, including 123 (83%) females and 26 (17%) males, with a mean age of 40±15 years, took part in the study. The mean (SD) basal Tg, TgAb, and TSH were 91.7±169.2 ng/mL (0.1-1000 ng/mL), 250±893 U/mL (0-9000 U/m L), and 64.8±61.5 µU/mL (30-689 U/mLµ), respectively. A total of 52 (34.9%) cases had TgAb levels greater than 100 U/mL. The mean basal Tg in patients who were admitted three or more times was significantly greater than that of patients with one hospitalization (p=0.026). In addition, the mean of Tg in patients who received 7.4 GBq radioactive iodine or less was significantly lower than the others (p=0.003). The mean of TgAb and TSH were not different between these groups. In the results of the whole body scans, patients with metastasis had higher frequency of hospitalization (p=0.010) and received higher radioactive iodine levels (p<0.001).
  
  
  CONCLUSIONS
  The findings of this study showed that, in differentiated thyroid cancer, lower basal serum Tg levels and absence of metastasis in radioiodine scan after ablation treatment were correlated with fewer hospitalizations and lower doses of radioactive iodine. Basal TgAb and TSH had no relation. Therefore, it seems that basal Tg could help us in determining which patients need aggressive treatment.
authors: Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Department of Nuclear Medicine, Tehran, Iran.
authors: Isa
authors: I
authors: Neshandar Asli
authors: Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Department of Nuclear Medicine, Tehran, Iran.
authors: Ali Shafiepour
authors: AS
authors: Siahkali
authors: Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Department of Nuclear Medicine, Tehran, Iran.
authors: Babak
authors: B
authors: Shafie
authors: Golestan University of Medical Sciences (GUOMS), Golestan Research Center of Gastroenterology and Hepatology (GRCGH), Gorgan, Iran.
authors: Hamid
authors: H
authors: Javadi
authors: Bushehr University of Medical Sciences, The Persian Gulf Nuclear Medicine Research Center, Bushehr, Iran.
authors: Majid
authors: M
authors: Assadi
keywords: anti-thyroglobulin; thyroglobulin; thyroid cancer